In Crohn’s disease (CD), evolving management goals emphasize a treat-to-target approach. The STRIDE II consensus, developed by healthcare providers (HCPs), aims for endoscopic healing and clinical remission. However, survey data reveal that HCPs and patients may differ in perspectives on symptoms like bowel urgency and fatigue. Addressing these patient experiences is essential for comprehensive CD management. HCPs can learn more here: https://e.lilly/3W94Oa0
Lilly Medical US’ Post
More Relevant Posts
-
Discover the future of healthcare with precision medicine at Granger Pharmacy! 🩺✨ Partnering with physicians, we deliver personalized treatments tailored just for you. Experience reduced side effects, enhanced efficiency, and improved disease management. Visit www.grangerrx.com today to learn more. #PrecisionMedicine #GrangerPharmacy #PersonalizedCare #HealthcareInnovation
-
-
Empower your patient care with precision and insight! Introducing Amerimmune's Standard Immunophenotyping Panel (SIP) – your go-to for swift screening of immune disorders and vigilant monitoring of immunodeficiency. 🌐🔬 Plus, gain crucial insights into your patients' risk of serious complications from SARS-CoV-2. Elevate your diagnostic capabilities and enhance patient outcomes with Amerimmune's advanced healthcare solutions. 🛡️💙 #AmerimmuneSIP #HealthcareInnovation #Immunophenotyping
-
-
P.A.D. affects 8 to 12 million people in the United States, especially those over 50. Many clinicians believe the number of people with PAD is much higher. Determining the actual prevalence of PAD is challenging because over 50% of low ABI cases are asymptomatic or exhibit atypical symptoms. In addition, comprehensive population screening studies using the gold standard are lacking. One in three diabetics over 50 suffer from PAD. Each year, approximately 150,000 lower limb amputations in the US can be attributed to PAD. Early identification and management of patients with PAD can help improve quality of life and longevity.
SCREENING FOR PAD // Screening and early diagnosis of PAD are critical to improving the impact this disease has on both patient outcomes and healthcare costs across the nation. We are calling on physicians to provide feedback to CMS to add Cat III CPT Code X171T to the OPPS fee schedule for non-contact near-infrared spectroscopy for screening of peripheral arterial disease. To submit comments to support the payment for this new code, follow the link to the CMS website https://hubs.la/Q01--ql60 Let's change the status quo together!
-
-
Effective care coordination and transition planning are essential to improving patient outcomes and eliminating unnecessary healthcare expenditures. This is especially true in the management of chronic kidney disease and end-stage renal disease. The complex, long-term nature of kidney disease requires consistent communication and collaboration among various providers. We cover this topic and strategies to improve care coordination and transitions in the latest Healthmap Solutions White Paper, “Care Coordination and Care Transitions In Value-based Kidney Disease Management.” Download it now from the link below: <<https://lnkd.in/dxYK-zCG>>
-
-
Axios International’s Access to Diagnosis Solutions are designed to help patients with a suspected diagnosis reach a confirmed diagnosis faster. The solutions minimize misdiagnosis, effectively navigate the treatment journey and maximize medical benefits. In the short term, we aim to streamline the path to confirmed diagnosis, address affordability barriers in diagnostic testing, and expedite the process, enabling quicker patient treatment access. In the long term, our goals include reducing misdiagnosis rates, early disease detection, raising overall disease understanding and public awareness, and improving referral networks to ensure seamless healthcare transitions. Find out more about Access to Diagnosis solutions at: https://lnkd.in/d2pnD3m7 #AccesstoDiagnosisSolutions #HealthcareAccess #PatientCentricity
-
How can you redefine Heritable Thoracic Aortic Disease care to reflect what really matters to patients? Developed by our HTAD experts and patient advocates, the Patient-Centered Quality Outcome Measures are a comprehensive set of 21 measures divided into 5 essential categories. These measures can help healthcare providers assess and improve the quality of care based on the real needs and priorities of their patients. Learn more about these measures ➡️ https://bit.ly/3UDwXWa #marfansyndrome #loeydietz #thoracic #aorticdiseases #rarediseases #patientcare #geneticdisorders #outcomes
-
-
#ICYMI: We presented at #JPM24 last week and shared the latest on Tenaya’s progress across our pipeline. Watch the presentation here: https://bit.ly/3tZ8hfA
Next week, Tenaya’s Chief Executive Officer Faraz Ali will present at the 42nd Annual J.P. Morgan Healthcare Conference. We’re looking forward to sharing the latest on Tenaya’s progress in advancing therapies that address the underlying drivers of heart disease. Read today’s press release for full presentation details: https://bit.ly/3tOGDln #JPM24
-
-
Your Participation Counts – Join the Crohn's Disease Clinical Trial Today! See if you qualify today! https://lnkd.in/gan_P5dx You may qualify to receive up to $2,000-$3,000 compensation upon enrollment in one of our Clinical Trials. #ibdawareness #ibdwarrior #crohns #crohnsdisease #ulcerativecolitis #colitis #chronicillness #clinicaltrial #clinicalresearch #researchstudy #medicalresearch #healthresearch #patientadvocacy #patientcare #patientexperience #patientempowerment #healthcare #healthylifestyle #healthandwellness #medicaladvancements #medicalbreakthrough #fightibd #beatcrohns #stopcolitis #chronsdiseaseawareness #colitisawareness #clinicaltrialparticipation #researchparticipants #healthresearcher #healthscience
-
-
Working to Fund A Cure #HSPandPLS Exe Dir, SP-Foundation.org / Pilot, MRPC GRR BOD
June 21-23, 2024! #TampaFL JOIN SP-Foundation make some NOISE for #spasticparaplegia. A rare disease group needs every member to help grow awareness. The 2024 SPF #HSPandPLS Annual Conference brings together patients, physicians, and researchers to really see YOU! Come share your story with others register online for in-person 21-23, 2024 or virtually! #hspandpls #spasticparaplegiafoundation #awarenesshspandpls #releasecures #curehspandpls #disabilityawareness #patientadvocate #patienteducation #findacure #championcures #releasecures
-
-
June 21-23, 2024! #TampaFL JOIN SP-Foundation make some NOISE for #spasticparaplegia. A rare disease group needs every member to help grow awareness. The 2024 SPF #HSPandPLS Annual Conference brings together patients, physicians, and researchers to really see YOU! Come share your story with others register online for in-person 21-23, 2024 or virtually! #hspandpls #spasticparaplegiafoundation #awarenesshspandpls #releasecures #curehspandpls #disabilityawareness #patientadvocate #patienteducation #findacure #championcures #releasecures
-
